StockClub

RDHL

RDHLRedHill Biopharma Ltd.$ --
RedHill Biopharma Ltd.

RedHill Biopharma Ltd.

RDHL

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 06/30/2025FY2025 Q2
Revenue
2M USD
YoY +58.6%
Operating Income
-2M USD
YoY +48.2%
Net Income
-2M USD
YoY -33.8%
EPS
-1$
YoY 0.0%

Revenue

$4.1M
FY2023 Q3$6M
$6M
Q3
FY2023 Q4$6.5M
$6.5M
Q4
FY2024 Q1$1.3M
$1.3M
Q1
FY2024 Q2$2.6M
$2.6M
Q2
FY2024 Q3$5.3M
$5.3M
Q3
FY2024 Q4$8M
$8M
Q4
FY2025 Q1$2M
$2M
Q1
FY2025 Q2$4.1M
$4.1M
Q2
Actual
+$1.5M (+58.6%)

Net Income

$-4.1M
FY2023 Q3$37.5M
$37.5M
Q3
FY2023 Q4$23.9M
$23.9M
Q4
FY2024 Q1$-1.5M
$-1.5M
Q1
FY2024 Q2$-3.1M
$-3.1M
Q2
FY2024 Q3$-5.7M
$-5.7M
Q3
FY2024 Q4$-8.3M
$-8.3M
Q4
FY2025 Q1$-2.1M
$-2.1M
Q1
FY2025 Q2$-4.1M
$-4.1M
Q2
Actual
$-1M (-33.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$64.4M
Est:$68.1M
FY2020MISS
$64.4M
FY2021MISS
Actual:$85.8M
Est:$87.9M
FY2021MISS
$85.8M
FY2022MISS
Actual:$61.8M
Est:$68M
FY2022MISS
$61.8M
FY2023MISS
Actual:$6.5M
Est:$9M
FY2023MISS
$6.5M
FY2024MISS
Actual:$8M
Est:$20.8M
FY2024MISS
$8M
FY2025MISS
Actual:$286,000
Est:$38M
FY2025MISS
$286,000

Analyst Estimates